Cytokine induction of Fas gene expression in insulin-producing cells requires the transcription factors NF-kappaB and C/EBP

Diabetes. 2001 Aug;50(8):1741-8. doi: 10.2337/diabetes.50.8.1741.

Abstract

Fas-mediated cell death may play a role in the autoimmune destruction of pancreatic beta-cells in type 1 diabetes. beta-Cells do not express Fas under physiological conditions, but Fas mRNA and protein are induced in cytokine-exposed mouse and human islets, rendering the beta-cells susceptible to Fas ligand-induced apoptosis. The aim of the present study was to investigate the molecular regulation of Fas by cytokines in rat beta-cells and in insulin-producing RINm5F cells. Fas mRNA expression was increased 15-fold in fluorescence-activated cell sorting-purified rat beta-cells exposed to interleukin (IL)-1beta, whereas gamma-interferon had no effect. Transfection experiments of rat Fas promoter-luciferase reporter constructs into purified rat beta-cells and RINm5F insulinoma cells identified an IL-1beta-responsive region between nucleotides -223 and -54. Inactivation of two adjacent NF-kappaB and C/EBP sites in this region abolished IL-1beta-induced Fas promoter activity in RINm5F cells. Binding of NF-kappaB and C/EBP factors to their respective sites was confirmed by gel shift assays. In cotransfection experiments, NF-kappaB p65 transactivated the Fas promoter. NF-kappaB p50 and C/EBPbeta overexpression had no effect by themselves on the Fas promoter activity, but when cotransfected with p65, each factor inhibited transactivation by p65. These results suggest a critical role for NF-kappaB and C/EBP factors in cytokine-regulation of Fas expression in insulin-producing cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-3-isobutylxanthine / pharmacology
  • Animals
  • CCAAT-Enhancer-Binding Protein-beta / genetics
  • CCAAT-Enhancer-Binding Protein-beta / metabolism*
  • Cytokines / pharmacology*
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / immunology*
  • Humans
  • Insulin / biosynthesis*
  • Insulinoma
  • Interferon-gamma / pharmacology
  • Interleukin-1 / pharmacology*
  • Mice
  • NF-kappa B / genetics
  • NF-kappa B / metabolism*
  • Pancreatic Neoplasms
  • Promoter Regions, Genetic*
  • Protein Biosynthesis / drug effects
  • Protein Biosynthesis / immunology
  • RNA, Messenger / genetics
  • Rats
  • Recombinant Proteins / pharmacology
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transcription Factors / metabolism
  • Transcription, Genetic / drug effects
  • Transcription, Genetic / immunology
  • Transcriptional Activation
  • Transfection
  • Tumor Cells, Cultured
  • fas Receptor / immunology*

Substances

  • CCAAT-Enhancer-Binding Protein-beta
  • Cytokines
  • Insulin
  • Interleukin-1
  • NF-kappa B
  • RNA, Messenger
  • Recombinant Proteins
  • Transcription Factors
  • fas Receptor
  • Interferon-gamma
  • 1-Methyl-3-isobutylxanthine